| US1209253A (en) | 1913-01-09 | 1916-12-19 | Automatic Electric Co | Impulse-transmitting device. |
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| JPS58403B2 (en) | 1975-07-24 | 1983-01-06 | 武田薬品工業株式会社 | L- Ascorbine Sanseizaino Seizouhou |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| US5135757A (en) | 1988-09-19 | 1992-08-04 | Edward Mendell Co., Inc. | Compressible sustained release solid dosage forms |
| IT1229203B (en) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| FR2704146B1 (en) | 1993-04-19 | 1995-07-13 | Cripdom | Microcapsules of acetylsalicylic acid with controlled release. |
| US5773025A (en) | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
| IT1270594B (en) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN |
| FR2725623A1 (en) | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | MEDICINAL AND / OR NUTRITION MICROCAPSULES FOR PER OS ADMINISTRATION |
| IL158466A0 (en) | 1997-04-15 | 2004-05-12 | Csir | Pharmaceutical compositions having appetite suppressant activity |
| US5891919A (en) | 1997-09-19 | 1999-04-06 | Burlington Bio-Medical & Scientific Corp. | Denatonium capsaicinate and methods of producing the same |
| US20040081697A1 (en)* | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| ITMI991316A1 (en) | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF MESALAZINE |
| IL132313A0 (en) | 1999-10-11 | 2001-03-19 | Yeda Res & Dev | Leptin assay |
| US20110217394A1 (en) | 2000-12-05 | 2011-09-08 | Brett Justin West | Iridoid Based Formulations |
| PL362687A1 (en)* | 2001-01-12 | 2004-11-02 | Sun Pharmaceutical Industries Limited | Spaced drug delivery system |
| AU2002307217A1 (en) | 2001-03-28 | 2002-10-15 | University Of South Florida | Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| US8030008B2 (en) | 2001-04-05 | 2011-10-04 | Senomyx, Inc. | Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators |
| FR2830447B1 (en)* | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | MICROPARTICULAR ORAL GALENIC FORM FOR DELAYED AND CONTROLLED RELEASE OF PHARMACEUTICAL ACTIVE INGREDIENTS |
| US6830759B2 (en)* | 2002-06-28 | 2004-12-14 | Ajinomoto Co., Inc. | Antidiabetic preparation for oral administration |
| US20060019346A1 (en) | 2002-07-29 | 2006-01-26 | Senomyx, Inc. | Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands |
| JP2005537298A (en)* | 2002-08-02 | 2005-12-08 | ペンウェスト ファーマシューティカルズ カンパニー | Metformin sustained release formulation |
| CN1413582A (en)* | 2002-11-29 | 2003-04-30 | 贵州圣济堂制药有限公司 | Dimethyldiguanide hydrochloride enteric solubility tablet and its preparation method |
| US7919236B2 (en) | 2002-12-18 | 2011-04-05 | Givaudan Sa | G-proteins |
| DE10308504A1 (en) | 2003-02-26 | 2004-09-09 | Basf Ag | Enzymatic production of (meth) acrylic acid esters |
| US20060172020A1 (en) | 2003-07-17 | 2006-08-03 | Djang Arthur H | Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabeties |
| KR20070053659A (en) | 2004-04-20 | 2007-05-25 | 도이체스 인스티튜트 퓌어 에른에룬그스포슝 | Agents of bitter receptors and uses thereof |
| US20060024335A1 (en) | 2004-07-29 | 2006-02-02 | Roger Stier E | Oral compositions which mask the bitter taste of a bitter-tasting agent |
| WO2006053771A2 (en) | 2004-11-18 | 2006-05-26 | Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Stiftung Des Öffentlichen Rechts | Agonists of bitter taste receptors and uses thereof |
| US20060222709A1 (en) | 2005-03-18 | 2006-10-05 | Agi Therapeutics Research Ltd. | Metformin methods and formulations for treating chronic constipation |
| WO2006118341A1 (en) | 2005-04-28 | 2006-11-09 | Ajinomoto Co., Inc. | Novel lactam compound |
| US20060269617A1 (en) | 2005-05-26 | 2006-11-30 | Suracell, Inc. | Supplement compositions and method of use for enhancement of insulin sensitivity |
| EP1907847A4 (en) | 2005-06-22 | 2009-07-01 | Senomyx Inc | Identification of human t2r receptors that are activated by bitter molecules in coffee (chlorogenic lactones) and related assays for identifying human bitter taste modulators |
| US20080274180A1 (en)* | 2005-08-30 | 2008-11-06 | Nicholas Piramal India Limited | Extended Release Pharmaceutical Composition of Metformin and a Process for Producing It |
| FR2891459B1 (en)* | 2005-09-30 | 2007-12-28 | Flamel Technologies Sa | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE INGREDIENT AND ORAL GALENIC FORM COMPRISING THE SAME |
| US20070104805A1 (en) | 2005-11-01 | 2007-05-10 | Udell Ronald G | Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives |
| JP2007215162A (en) | 2006-01-11 | 2007-08-23 | Canon Inc | Information processing apparatus, control method thereof, program and recording medium |
| US20070207227A1 (en) | 2006-02-23 | 2007-09-06 | Conopco, Inc., D/B/A Unilever, A Corporation Of New York | Appetite suppressant compositions |
| WO2007116404A2 (en) | 2006-04-10 | 2007-10-18 | Bar-Ilan University | Cucurbitacin glucosides and use thereof in treating cancer |
| CA2551706A1 (en) | 2006-06-27 | 2007-12-27 | Innovative Life Sciences Corporation | Herbal product comprising cinnamon and bitter melon |
| CN100596277C (en) | 2006-07-10 | 2010-03-31 | 博仲盛景医药技术（北京）有限公司 | Medicinal composition for promoting enterogastric peristalsis |
| CN101505771A (en) | 2006-08-17 | 2009-08-12 | 荷兰联合利华有限公司 | Processes for production of HOODIA plant extracts containing steroidal glycosides |
| EP2054071A1 (en) | 2006-08-24 | 2009-05-06 | Unilever N.V. | Process for preparing a composition comprising steroidal glycosides |
| CN101522702A (en) | 2006-09-05 | 2009-09-02 | 塞诺米克斯公司 | Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators |
| EP1975612A1 (en) | 2007-03-29 | 2008-10-01 | Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand | Agonists of bitter taste receptors and uses thereof |
| EP1975611A1 (en) | 2007-03-29 | 2008-10-01 | Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand | Agonists of bitter taste receptors and uses thereof |
| US20090042813A1 (en) | 2007-08-10 | 2009-02-12 | Sergey Michailovich Melnikov | Hoodia extract oil compositions comprising medium chain triglycerides |
| US20100316736A1 (en) | 2007-10-24 | 2010-12-16 | Desert Labs Agriculture Cooperative Association Ltd. | Appetite suppressant |
| US20100330205A1 (en) | 2008-01-29 | 2010-12-30 | Nakamori Pharmaceutical Co., Ltd. | Pharmaceutical composition |
| WO2009140784A1 (en) | 2008-05-23 | 2009-11-26 | Givaudan Sa | Bitter alkaloid containing consumables comprising bitter blockers |
| EP2300830B1 (en) | 2008-06-13 | 2015-05-20 | Givaudan SA | Methods of identifying modulators of the bitter taste receptor tas2r44 |
| WO2010022529A1 (en) | 2008-08-29 | 2010-03-04 | Givaudan Sa | Methods to identify modulators |
| JP5539881B2 (en) | 2008-08-29 | 2014-07-02 | サントリーホールディングス株式会社 | Novel epigallocatechin gallate tetramer and vascular endothelial function improving agent containing them |
| WO2010060198A1 (en) | 2008-11-26 | 2010-06-03 | West Central Envirotech Inc. | Composition and method for controlling insects |
| CA2748729A1 (en) | 2009-01-03 | 2010-07-08 | Shizuoka Prefecture Public University Corporation | Sulfated c-glycoside, method for isolating same and method for synthesizing same |
| US8709745B2 (en) | 2009-07-28 | 2014-04-29 | Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke | Methods for isolating ligands of the human bitter taste receptor TAS2R49 |
| ES2437921T3 (en) | 2009-10-21 | 2014-01-15 | Wisconsin Alumni Research Foundation | Method to prevent type 1 diabetes |
| JP2013512908A (en) | 2009-12-04 | 2013-04-18 | コルゲート・パーモリブ・カンパニー | Oral compositions containing extracts of Garcinia mangostana L and related methods |
| EP2345646A1 (en) | 2010-01-14 | 2011-07-20 | InterMed Discovery GmbH | Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions |
| US20110293753A1 (en) | 2010-05-28 | 2011-12-01 | Louis Bellafiore | Tocotrienol Compositions |
| GB201009873D0 (en) | 2010-06-14 | 2010-07-21 | Univ Leuven Kath | Method for hydrogenation of isoalpha-acids (isohumulones) to hexahydro-iso-alpha-acids (hexahydro-isohumulones) by using heterogeneous ruthenium |
| EP2397039A1 (en) | 2010-06-21 | 2011-12-21 | Abbott Laboratories | Compositions for delaying progression of diabetes using Salacia oblonga extract |
| CN101978956B (en)* | 2010-10-13 | 2012-03-28 | 北京京丰制药有限公司 | Metformin hydrochloride enteric-coated tablets and preparation method thereof |
| WO2013103919A2 (en) | 2012-01-06 | 2013-07-11 | Elcelyx Therapeutics, Inc. | Compositions and methods for treating metabolic disorders |
| CN103597071A (en)* | 2011-01-07 | 2014-02-19 | 埃尔舍利克斯治疗公司 | Chemosensory receptor ligand-based therapies |
| CN103768071B (en)* | 2012-10-23 | 2016-08-17 | 中国医药工业研究总院 | A kind of oral formulations treating diabetes |